Invesco Biotechnology & Genome ETF Rating $80.70 +0.31 (+0.39%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.65Holdings in PBE have an aggregate rating of Moderate Buy based on 401 analyst ratings issued in the past year covering 25 companies (89.5% of the portfolio).PBE Aggregate Price Target$80.70High Prediction$80.70Average Prediction$80.70Low Prediction$80.70Holdings in PBE have an aggregate price target of $80.70 and a range of $80.70 to $80.70 covering 25 companies (89.5% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PBE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.21%UTHRUnited Therapeutics$572.20-1.6%3.5587 of 5 stars2.77$601.50 5.1%13Upcoming EarningsInsider Trade5.39%ILMNIllumina$139.07-0.2%3.0776 of 5 stars2.22$131.06 -5.8%18Earnings ReportAnalyst Forecast5.04%REGNRegeneron Pharmaceuticals$702.45-1.0%4.528 of 5 stars2.77$826.59 17.7%26Earnings ReportDividend AnnouncementAnalyst Upgrade4.90%BIIBBiogen$189.13+1.0%3.8003 of 5 stars2.50$214.23 13.3%28Earnings ReportAnalyst Upgrade4.85%INCYIncyte$97.47+0.3%4.0887 of 5 stars2.43$104.26 7.0%21Earnings ReportAnalyst Forecast4.76%ALNYAlnylam Pharmaceuticals$301.11+1.1%4.3503 of 5 stars2.77$471.96 56.7%26Earnings ReportAnalyst Upgrade4.66%AMGNAmgen$329.59+1.8%4.4701 of 5 stars2.42$357.12 8.4%31Trending NewsEarnings ReportAnalyst Forecast4.58%GILDGilead Sciences$133.48+0.6%4.836 of 5 stars2.86$157.35 17.9%28Upcoming Earnings3.39%TGTXTG Therapeutics$36.10+1.1%3.9581 of 5 stars2.57$50.00 38.5%7Upcoming Earnings3.32%BCRXBioCryst Pharmaceuticals$9.03-1.8%3.777 of 5 stars2.77$19.64 117.5%13News CoverageUpcoming Earnings3.28%ARWRArrowhead Pharmaceuticals$74.93-1.9%2.6361 of 5 stars2.83$84.20 12.4%12News CoverageUpcoming Earnings3.24%PTGXProtagonist Therapeutics$99.21-0.3%1.7014 of 5 stars2.80$108.15 9.0%15News CoveragePositive NewsEarnings ReportUpcoming Earnings3.20%CPRXCatalyst Pharmaceuticals$30.86+6.6%4.7689 of 5 stars3.50$34.00 10.2%6Upcoming Earnings3.12%CDNACareDx$20.70-1.2%2.5526 of 5 stars2.00$25.00 20.8%6Earnings ReportAnalyst Upgrade3.08%RPRXRoyalty Pharma$50.44+0.5%3.6243 of 5 stars3.00$50.33 -0.2%6Positive NewsUpcoming Earnings2.81%EXELExelixis$44.42+0.6%3.3604 of 5 stars2.39$47.00 5.8%23Positive NewsEarnings Report2.80%PTCTPTC Therapeutics$65.04-0.7%3.8162 of 5 stars2.63$84.40 29.8%16News CoverageUpcoming Earnings2.76%NBIXNeurocrine Biosciences$135.06+0.7%4.3717 of 5 stars2.82$180.45 33.6%222.72%VCYTVeracyte$32.97-1.4%2.4978 of 5 stars2.38$43.83 32.9%8News CoverageEarnings Report2.66%TECHBio-Techne$56.68+3.5%4.2711 of 5 stars2.71$72.77 28.4%14Positive NewsUpcoming EarningsGap Up2.63%VCELVericel$36.81+0.9%3.7621 of 5 stars2.63$55.40 50.5%8Upcoming Earnings2.63%HALOHalozyme Therapeutics$65.87+2.0%4.2853 of 5 stars2.42$79.11 20.1%12Upcoming EarningsInsider Trade2.52%ACADACADIA Pharmaceuticals$22.35+0.7%4.5297 of 5 stars2.75$31.21 39.6%20Upcoming Earnings2.47%RGENRepligen$125.61+6.3%3.859 of 5 stars2.86$168.75 34.3%14Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume2.44%TBPHTheravance Biopharma$16.73-1.1%3.2573 of 5 stars2.75$21.83 30.5%8Analyst Downgrade This page (NYSEARCA:PBE) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | SponsoredInvest in SpaceX Before IPOSpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...NXT Wave Research | SponsoredURGENT: $2 Gold Stock With Major DiscoveryA $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBE Stock Alerts